Showing 17,661 - 17,680 results of 63,578 for search '(( 2 e decrease ) OR ( 50 ((((ms decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.63s Refine Results
  1. 17661

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”
  2. 17662
  3. 17663
  4. 17664
  5. 17665
  6. 17666

    Regulation of USP2a and MDM2 in response to <i>as-</i>APF. (A by Jayoung Kim (153487)

    Published 2013
    “…Western blot with anti-USP2a antibody showed that the level of USP2a level was stably decreased in response to <i>as</i>-APF treatment, but this was only transiently reduced by control mock APF peptide. …”
  7. 17667

    OGD in lG partly preserves Δψ<sub>m</sub> (i.e. delays depolarization) caused by subsequent NaN<sub>3</sub> treatment. by Andrej Korenić (529339)

    Published 2014
    “…Depolarization is visible in the normoxic group (b, c) (seen as concentration-dependent decrease in magenta and increase in blue color), but it is more pronounced than in OGD group after treatment with NaN<sub>3</sub> (e, f). …”
  8. 17668
  9. 17669
  10. 17670

    Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis by Benjamin Birkner (8212203)

    Published 2020
    “…We compared continuing treatment (standard care) to a tapering approach (i.e., an immediate 50% dose reduction), withdrawal (i.e., an immediate 100% dose reduction) and tapering followed by withdrawal of bDMARDs. …”
  11. 17671

    DNMT1 reduces cisplatin sensitivity partially through downregulating FOXO3a in ovarian cancer cells by Chong Guo (5819105)

    Published 2025
    “…Knocking down of DNMT1 could decrease the IC<sub>50</sub> of cisplatin. Treatment with cisplatin may reduce FOXO3a expression in OC cells. …”
  12. 17672

    Effect of Oxidative Phosphorylation Inhibitors on <i>In Vivo</i> Tat Transport and Sensitivity of Fluorescence Detection on Plates. by Umesh K. Bageshwar (2271628)

    Published 2016
    “…The SsrA tag decreased the mCherry fluorescence intensity (II; 63±14%), consistent with a decrease in cytoplasmic mCherry concentration due to SsrA-dependent degradation. …”
  13. 17673
  14. 17674
  15. 17675
  16. 17676

    Immunocontraceptive target repertoire defined by systematic identification of sperm membrane alloantigens in a single species by Nathaly Cormier (4775262)

    Published 2018
    “…Less abundant alloantigens included ATP synthase F1 β subunit, myo-inositol monophosphatase-1, and zymogen granule membrane glycoprotein-2. Immunodominant sperm lipid raft alloantigens included SAMP14, lymphocyte antigen 6K, and the epididymal sperm protein E12. …”
  17. 17677
  18. 17678
  19. 17679
  20. 17680